Journal profile · Otorhinolaryngology

Clinical and Experimental Otorhinolaryngology

ISSN 1976-8710 · eISSN 2005-0720 · Korean Society of Otolaryngology · SOUTH KOREA · Quarterly · Founded 2008

Clinical and Experimental Otorhinolaryngology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.75; fully open access; APC about USD 1,000; median 111 days to acceptance (93 articles, last 24 months); community-reported acceptance: easy; 47 articles in 2025; indexed in SCIE and Scopus; the journal's website says it has moved to a new publisher.

The journal's website says it has moved to a new publisher: CEO provides the electronic backup and preservation of access to the journal content in the event the journal is no longer published by archiving in PubMed Central and National Library of Korea. Source ↗Publisher website ·

Impact factor2.75Latest value listed by LetPub
CAS zoneZone 3 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 2 · Medicine
Review time111 daysMedian, submission to acceptance · 93 articles, last 24 months · Crossref
APCUSD 1,000Fully open access
AcceptanceEasyCommunity average
Articles per year472025 · OpenAlex count

Scope

Aims, scope and focus

Clinical and Experimental Otorhinolaryngology is published by Korean Society of Otolaryngology and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Hearing, Cochlea, Tinnitus, Genetics, Ear Surgery and Otitis Media and Vestibular and auditory disorders, together about 28.6% of its articles. Its main subfields are Otorhinolaryngology. (generated from OpenAlex topic counts and CAS ranking data)

Clinical and Experimental Otorhinolaryngology (Clin Exp Otorhinolaryngol, CEO) is an international, peer-reviewed journal that publishes high-quality articles on recent advances in otorhinolaryngology–head and neck surgery. The journal is dedicated to advancing patient care in disorders of the ear, nose, throat, head, and neck. CEO publishes original research articles, clinical trials, and review articles covering both clinical and basic science research across the full spectrum of otorhinolaryngology–head and neck surgery. All manuscripts containing research data undergo rigorous peer review. Submitted manuscripts must not have been previously published or be under consideration for publication elsewhere. Founded in 2008, CEO is published in English quarterly (February, May, August, and November) by the Korean Society of Otorhinolaryngology–Head and Neck Surgery. The journal aims to disseminate scientifically rigorous, evidence-based research from diverse subspecialties within the field.

From the journal's Aims & Scope

Research area (LetPub): Otorhinolaryngology

Editor-in-chief Hyun-Woo ShinPublisher website

Editorial board by country: none in mainland China; most named South Korea 51, United States 20, Japan 5, Taiwan, China 2, Italy 2 (86 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Hearing, Cochlea, Tinnitus, GeneticsNeuroscience11.4%
  2. Ear Surgery and Otitis MediaMedicine9.4%
  3. Vestibular and auditory disordersNeuroscience7.7%
  4. Sinusitis and nasal conditionsMedicine7.5%
  5. Hearing Loss and RehabilitationNeuroscience7.4%
  6. Nasal Surgery and Airway StudiesMedicine5.9%
  7. Obstructive Sleep Apnea ResearchMedicine4.5%
  8. Head and Neck Cancer StudiesMedicine4.5%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
LevelCategoryZone
MajorMedicineZone 3
MinorOtorhinolaryngologyZone 3

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
LevelCategoryZone
MajorMedicineZone 2
MinorOtorhinolaryngologyZone 2

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
LevelCategoryZone
MajorMedicineZone 3
MinorOtorhinolaryngologyZone 2

Top journal: noReview journal: no

Database indexing

SCIEScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

PMCPubMedPublisher website

Other: Google Scholar, Naver, Crossref, KoreaMed, Korea Citation Index (KCI)

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
2.75LetPub ·
Impact factor (publisher)
2.8Publisher website ·
CiteScore 2026-06
5.8LetPub ·
CiteScore (publisher)
5.8Publisher website ·
SJR 2026-06
1.04LetPub ·
SNIP 2026-06
1.6LetPub ·
h-index
21LetPub ·
h-index
54OpenAlex ·
i10-index
573OpenAlex ·
2-year mean citedness
2.52OpenAlex ·
Self-citation rate
10.7%LetPub ·
Share of gold OA articles
99.18%LetPub ·

Volume

Articles per year
43LetPub ·

Articles by year OpenAlex count · 1,014 in total · the current year is incomplete

YearArticlesOpen accessCitations
202645455
2025474796
20244040231
20233939379
20225353717
20213636357

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with Crossref · to

111 daysMedian, submission to acceptance · P25–P75 75 days – 139 days

Acceptance to online
median 109 days (93 articles)
Submission to online
median 218 days
Sample
93 articles with submission and acceptance dates (111 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
6–12 weeksLetPub ·
Average acceptance (community reports)
EasyLetPub ·
Acceptance rate (publisher)
14.9%Publisher website ·
Submission to first decision
13.6 daysPublisher website ·
Submission to publication (journal-reported)
about 18 weeksDOAJ ·
Peer review
Double anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJUSD 1,000NoCC BY-NC
OpenAlexUSD 300——
LetPubUSD 300No—
Publisher websiteYes, amount not published——

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

Article types accepted8
  1. brief communicationpublishing full-length Original article, Review article, Guidelines, Correspondence, Brief communication, How I do it and EditorialsLength not stated
  2. correspondencepublishing full-length Original article, Review article, Guidelines, Correspondence, Brief communication, How I do it and EditorialsLength not stated
  3. editorialEditorialLength not stated
  4. editorialspublishing full-length Original article, Review article, Guidelines, Correspondence, Brief communication, How I do it and EditorialsLength not stated
  5. guidelinespublishing full-length Original article, Review article, Guidelines, Correspondence, Brief communication, How I do it and EditorialsLength not stated
  6. how i do itpublishing full-length Original article, Review article, Guidelines, Correspondence, Brief communication, How I do it and EditorialsLength not stated
  7. original articlepublishing full-length Original article, Review article, Guidelines, Correspondence, Brief communication, How I do it and EditorialsLength not stated
  8. review articlepublishing full-length Original article, Review article, Guidelines, Correspondence, Brief communication, How I do it and EditorialsLength not stated
Publisher website
Policy excerpts from the journal's websiteOpen access, Peer review, Plagiarism, Preprints
Open access

Copyright, Open Access, and Archiving Policy Model summary

Copyright, Open Access, and Archiving Policy

Source ↗Publisher website ·
Peer review

Secondary publication allowed per ICMJE Model summary

It is possible to republish manuscripts if the manuscripts satisfy the conditions of secondary publication of the ICMJE Recommendations

Source ↗Publisher website ·
Plagiarism

Plagiarism screening with Similarity Check Model summary

Submitted manuscripts are screened for possible plagiarism or duplicate publication by the use of Similarity Check upon arrival.

Source ↗Publisher website ·
Preprints

Principles of Transparency and Best Practice Model summary

Principles of Transparency and Best Practice

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Korean Society of Otolaryngology
Country or region
SOUTH KOREA
Language
English
Frequency
Quarterly
Founded
2008
ISSN
1976-8710
Electronic ISSN
2005-0720
Latest issue on the website
Volume 19 (August 2026)
Official links

FAQ

Frequently asked questions about Clinical and Experimental Otorhinolaryngology

What CAS zone is Clinical and Experimental Otorhinolaryngology in?

In the 2025 upgraded edition of the CAS Journal Ranking, Clinical and Experimental Otorhinolaryngology is in Zone 3 of Medicine, and in Zone 3 of the minor category Otorhinolaryngology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Clinical and Experimental Otorhinolaryngology?

The latest impact factor listed by LetPub is 2.75; CiteScore 5.8, h-index 54.

How long does peer review take at Clinical and Experimental Otorhinolaryngology?

Based on the dates recorded on 93 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 111 days (interquartile range 75–139 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”; the journal's website gives an acceptance rate of 14.9%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Where are the editorial board members of Clinical and Experimental Otorhinolaryngology based?

Of the 86 board members whose country the journal's board page names, none are in mainland China; the countries named most often are South Korea (51), United States (20) and Japan (5). Counted from the institutions listed on the board page; for reference only.

Which databases index Clinical and Experimental Otorhinolaryngology?

According to LetPub and DOAJ records, Clinical and Experimental Otorhinolaryngology is indexed in SCIE, Scopus and DOAJ. The journal's website also lists PMC and PubMed; that list has not been checked against each database.

Is Clinical and Experimental Otorhinolaryngology open access, and what is the APC?

Clinical and Experimental Otorhinolaryngology is a fully open-access journal. APC about USD 1,000.

Sources and updates

The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .